Literature DB >> 18060753

n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms.

C Torrejon1, U J Jung, R J Deckelbaum.   

Abstract

Cardiovascular disease and atherosclerosis are a leading cause of morbidity and mortality worldwide. Epidemiological studies and randomized control intervention trials have reported that n-3 fatty acids reduce cardiovascular events. A variety of biologic and molecular effects of n-3 fatty acids can modulate the mechanisms of development and progression of atherosclerosis. These include n-3 fatty acid effects on inflammation, cardiac excitability, platelet function, triglyceride blood levels, blood pressure and the stability of atheroma plaques. The molecular mechanisms are still not fully defined; but might involve changes in membrane fluidity, receptor responses and binding to intracellular receptors regulating gene transcription. Understanding and elucidating these mechanisms is important to development of future strategies for prevention and treatment of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060753      PMCID: PMC2386438          DOI: 10.1016/j.plefa.2007.10.014

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  98 in total

Review 1.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

Authors:  R Virmani; F D Kolodgie; A P Burke; A Farb; S M Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

Review 2.  Fatty acid modulation of endothelial activation.

Authors:  R De Caterina; J K Liao; P Libby
Journal:  Am J Clin Nutr       Date:  2000-01       Impact factor: 7.045

3.  Eicosapentaenoic acid and docosahexaenoic acid selectively attenuate U46619-induced smooth muscle cell proliferation.

Authors:  R Pakala; R Pakala; C Benedict
Journal:  Lipids       Date:  1999-09       Impact factor: 1.880

4.  Long-term fish consumption is associated with protection against arrhythmia in healthy persons in a Mediterranean region--the ATTICA study.

Authors:  Christina Chrysohoou; Demosthenes B Panagiotakos; Christos Pitsavos; John Skoumas; Xenofon Krinos; Yannis Chloptsios; Vassilios Nikolaou; Christodoulos Stefanadis
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

5.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

Authors:  Mitsuhiro Yokoyama; Hideki Origasa; Masunori Matsuzaki; Yuji Matsuzawa; Yasushi Saito; Yuichi Ishikawa; Shinichi Oikawa; Jun Sasaki; Hitoshi Hishida; Hiroshige Itakura; Toru Kita; Akira Kitabatake; Noriaki Nakaya; Toshiie Sakata; Kazuyuki Shimada; Kunio Shirato
Journal:  Lancet       Date:  2007-03-31       Impact factor: 79.321

Review 6.  n-3 PUFA in CVD: influence of cytokine polymorphism.

Authors:  C von Schacky
Journal:  Proc Nutr Soc       Date:  2007-05       Impact factor: 6.297

7.  Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.

Authors:  Sandeep Bansal; Julie E Buring; Nader Rifai; Samia Mora; Frank M Sacks; Paul M Ridker
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

8.  Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

Authors:  Børge G Nordestgaard; Marianne Benn; Peter Schnohr; Anne Tybjaerg-Hansen
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

9.  Food omega-3 fatty acid intake of individuals (total, linolenic acid, long-chain) and their blood pressure: INTERMAP study.

Authors:  Hirotsugu Ueshima; Jeremiah Stamler; Paul Elliott; Queenie Chan; Ian J Brown; Mercedes R Carnethon; Martha L Daviglus; Ka He; Alicia Moag-Stahlberg; Beatriz L Rodriguez; Lyn M Steffen; Linda Van Horn; John Yarnell; Beifan Zhou
Journal:  Hypertension       Date:  2007-06-04       Impact factor: 10.190

10.  Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.

Authors:  Nadeem Sarwar; John Danesh; Gudny Eiriksdottir; Gunnar Sigurdsson; Nick Wareham; Sheila Bingham; S Matthijs Boekholdt; Kay-Tee Khaw; Vilmundur Gudnason
Journal:  Circulation       Date:  2006-12-26       Impact factor: 29.690

View more
  16 in total

1.  Analysis of fatty acids in 12 Mediterranean fish species: advantages and limitations of a new GC-FID/GC-MS based technique.

Authors:  Teresina Nevigato; Maurizio Masci; Elena Orban; Gabriella Di Lena; Irene Casini; Roberto Caproni
Journal:  Lipids       Date:  2012-05-30       Impact factor: 1.880

2.  Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome.

Authors:  Susan Sergeant; Christina E Hugenschmidt; Megan E Rudock; Julie T Ziegler; Priscilla Ivester; Hannah C Ainsworth; Dhananjay Vaidya; L Douglas Case; Carl D Langefeld; Barry I Freedman; Donald W Bowden; Rasika A Mathias; Floyd H Chilton
Journal:  Br J Nutr       Date:  2011-07-04       Impact factor: 3.718

3.  ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3.

Authors:  Man Yu; Aaron Benham; Sreemathi Logan; R Steven Brush; Md Nawajes A Mandal; Robert E Anderson; Martin-Paul Agbaga
Journal:  J Lipid Res       Date:  2011-12-09       Impact factor: 5.922

4.  ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis.

Authors:  Yusuke Ohno; Shota Suto; Masao Yamanaka; Yukiko Mizutani; Susumu Mitsutake; Yasuyuki Igarashi; Takayuki Sassa; Akio Kihara
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

Review 5.  Altered cholesterol and fatty acid metabolism in Huntington disease.

Authors:  Robert C Block; E Ray Dorsey; Christopher A Beck; J Thomas Brenna; Ira Shoulson
Journal:  J Clin Lipidol       Date:  2010 Jan-Feb       Impact factor: 4.766

6.  Dietary fat quality and coronary heart disease prevention: a unified theory based on evolutionary, historical, global, and modern perspectives.

Authors:  Christopher E Ramsden; Keturah R Faurot; Pedro Carrera-Bastos; Loren Cordain; Michel De Lorgeril; Laurence S Sperling
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-08

Review 7.  Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease.

Authors:  Delphine Fontaine; Sandy Figiel; Romain Félix; Sana Kouba; Gaëlle Fromont; Karine Mahéo; Marie Potier-Cartereau; Aurélie Chantôme; Christophe Vandier
Journal:  J Lipid Res       Date:  2020-04-07       Impact factor: 5.922

8.  Low n-6/n-3 PUFA Ratio Improves Lipid Metabolism, Inflammation, Oxidative Stress and Endothelial Function in Rats Using Plant Oils as n-3 Fatty Acid Source.

Authors:  Li Gang Yang; Zhi Xiu Song; Hong Yin; Yan Yan Wang; Guo Fang Shu; Hui Xia Lu; Shao Kang Wang; Gui Ju Sun
Journal:  Lipids       Date:  2015-11-02       Impact factor: 1.880

9.  Omega-3 and renal function in older adults.

Authors:  F Lauretani; M Maggio; F Pizzarelli; S Michelassi; C Ruggiero; G P Ceda; S Bandinelli; L Ferrucci
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 10.  Effect of fish oil on arrhythmias and mortality: systematic review.

Authors:  Hernando León; Marcelo C Shibata; Soori Sivakumaran; Marlene Dorgan; Trish Chatterley; Ross T Tsuyuki
Journal:  BMJ       Date:  2008-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.